Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Goodrx Holdings Inc Cl A
(NQ:
GDRX
)
6.690
-0.040 (-0.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Goodrx Holdings Inc Cl A
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call
April 11, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings
April 10, 2024
GoodRx Holdings Inc (NASDAQ: GDRX) got an upgrade last month from Wells Fargo analyst.
Via
Benzinga
Why GoodRx Surged Today
March 25, 2024
The prescription-drug upstart got an upgrade from Wall Street.
Via
The Motley Fool
Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says
March 25, 2024
Wells Fargo's upgrade of GoodRx Holdings. Analysts anticipate strong revenue visibility and EBITDA margins, setting the stage for potential stock outperformance in 2024-2025.
Via
Benzinga
The Latest Analyst Ratings For GoodRx Holdings
March 25, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
In-Depth Examination Of 4 Analyst Recommendations For GoodRx Holdings
February 26, 2024
Via
Benzinga
Unveiling 7 Analyst Insights On GoodRx Holdings
January 02, 2024
Via
Benzinga
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.
Via
Benzinga
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
March 25, 2024
U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
GoodRx Interim CEO Extends Commitment to Company
March 14, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
These Analysts Increase Their Forecasts On GoodRx Following Q4 Earnings
March 01, 2024
GoodRx Holdings, Inc. (NASDAQ: GDRX) reported upbeat fourth-quarter FY23 results and issued first-quarter revenue guidance above estimates.
Via
Benzinga
Why GoodRx Stock Soared Today
February 29, 2024
The company beat Q4 estimates, announced a new share repurchase authorization, and issued strong guidance.
Via
The Motley Fool
GoodRx (GDRX) Q4 2023 Earnings Call Transcript
February 29, 2024
GDRX earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Is Telemedicine Firm GoodRx's Shares Surging Today
February 29, 2024
GoodRx Holdings reported strong Q4 results and issued above-estimate revenue guidance for FY24. Revenue and adjusted EBITDA increased, company also announced new stock repurchase program.
Via
Benzinga
GoodRx Reports Fourth Quarter and Full Year 2023 Results
February 29, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
This healthcare stock making a buzz with 160% growth
February 26, 2024
Healthcare stocks are typically on the boring side of the spectrum, that is until you add a bit of technology and the right niche to them.
Via
MarketBeat
Topics
Economy
Exposures
Economy
GoodRx to Participate in Upcoming Investor Conferences
February 20, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
Gene therapy: Why does it cost millions for a single treatment?
February 15, 2024
Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology.
Via
MarketBeat
Exposures
Product Safety
GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
February 01, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Announces Proposed Refinancing of First Lien Credit Facilities
January 22, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings
January 11, 2024
From
GoodRx
Via
Business Wire
Prescription Drug Discount Provider GoodRx Expects To Build Momentum In 2024, Stock Soars
January 10, 2024
GoodRx Holdings Inc (NASDAQ: GDRX) provided preliminary Q4 FY23 revenue of $195 million-$197 million, up 6%-7% Y/Y, versus the consensus of $190.77 million.
Via
Benzinga
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 10, 2024
Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.
Via
Benzinga
GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024
January 10, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
Election Edge: 7 Stocks to Snag Before the 2024 Presidential Race Heats Up
January 09, 2024
Election stocks include companies at the center of national conversation and those likely to get increased government funding.
Via
InvestorPlace
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
January 02, 2024
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
GoodRx Appoints Kelly J. Kennedy to Board of Directors
December 22, 2023
From
GoodRx
Via
Business Wire
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 02, 2024
Shares of Longboard Pharmaceuticals, Inc.
Via
Benzinga
GoodRx to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 13, 2023
From
GoodRx Holdings, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.